Medicinal Products

Loquen XR 300 mg tablete s produljenim oslobađanjem

Name Loquen XR 300 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-899405923
Active Substance kvetiapinfumarat
Composition svaka tableta sadrži 300 mg kvetiapina u obliku kvetiapinfumarata
Pharmaceutical Form tableta s produljenim oslobađanjem
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-899405923-01]
20 tableta u blisteru, u kutiji  [HR-H-899405923-02]
30 tableta u blisteru, u kutiji  [HR-H-899405923-03]
50 tableta u blisteru, u kutiji  [HR-H-899405923-04]
50 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-899405923-05]
56 tableta u blisteru, u kutiji  [HR-H-899405923-06]
60 tableta u blisteru, u kutiji  [HR-H-899405923-07]
90 tableta u blisteru, u kutiji  [HR-H-899405923-08]
100 tableta u blisteru, u kutiji  [HR-H-899405923-09]
60 tableta u bočici, u kutiji  [HR-H-899405923-10]
100 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-899405923-11]
Manufacturer Teva Gyogyszergyar Zrt., Debrecen, Mađarska
Pharmachemie B.V., Haarlem, Nizozemska
Teva Czech Industries s.r.o., Opava-Komarov, Češka
Teva Operations Poland Sp. z o.o., Krakow, Poljska
Teva Pharma S.L.U., Zaragoza, Španjolska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Adamed Sp. z o.o., Czosnow, Poljska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 08.05.2019
MA Period of Validity unlimited
Classification Number UP/I-530-09/18-02/164
Registration Number 381-12-01/38-19-03
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja, verzija 3
Back